Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neupro's Multicenter and Prospective Observation of Safety and Efficacy in Chinese Mainland Idiopathic Parkinson's Disease in Real World Practice

NCT04957420 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04957420
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04957420 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neupro's Multicenter and Prospective Observation of Safety and Efficacy in Chinese Mainland Idiopathic Parkinson's Disease in Real World Practice
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
April 30, 2022
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease